Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
September 14, 2023 09:41 ET
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral...